Literature DB >> 33878994

Gallbladder carcinosarcoma: current perspectives and new development.

Xiaorong Chen1, Yuwen Zhou2, Xinyao Shu1, Guixia Wei1, Meng Qiu1.   

Abstract

Introduction: Gallbladder carcinosarcoma (GBCS) is a rare neoplasm, and previous studies regarding to GBCS were case reports/case series, absence of large retrospective analyses, or systemic review. This review summarizes the current literature on accurate information of GBCS to assist clinicians to accurately diagnose and treat this malignancy.Areas covered: The authors retrieved relevant documents of GBCS from PubMed and Medline. This review elaborates on the knowledge of GBCS covering epidemiology, potential mechanism, clinical manifestation, diagnosis, treatment, and prognosis.Expert opinion: The majority of GBCS patients are easily misdiagnosed as GBC and usually treated as GBC. However, the biological behavior and outcome of GBCS is different from that of GBC. GBCS should be considered as a separate disease.

Entities:  

Keywords:  Carcinosarcoma; epithelial; gallbladder; mesenchymal; treatment

Mesh:

Year:  2021        PMID: 33878994     DOI: 10.1080/17474124.2021.1919509

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  1 in total

1.  Complete Response to Combined Chemotherapy and Anti-PD-1 Therapy for Recurrent Gallbladder Carcinosarcoma: A Case Report and Literature Review.

Authors:  Qin-Qin Liu; Hao-Ming Lin; Hong-Wei Han; Cai-Ni Yang; Chao Liu; Rui Zhang
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.